Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.

J Cardiovasc Electrophysiol. 2019 Nov 7. doi: 10.1111/jce.14260. [Epub ahead of print]

PMID:
31701593
2.

Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.

Yamaji H, Higashiya S, Murakami T, Hina K, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.

J Cardiovasc Pharmacol. 2019 Sep;74(3):246-254. doi: 10.1097/FJC.0000000000000703.

PMID:
31498193
3.

Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.

Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K.

J Thromb Thrombolysis. 2019 May;47(4):487-494. doi: 10.1007/s11239-019-01835-8.

PMID:
30955142
4.

A novel electron emission-based cell culture device promotes cell proliferation and differentiation of pre-osteoblastic MC3T3-E1 cells.

Sugimori F, Hirakawa H, Tsutsui A, Yamaji H, Komaru S, Takasaki M, Iwamatsu T, Uemura T, Uemura Y, Morita K, Tsumura T.

PLoS One. 2019 Mar 28;14(3):e0213579. doi: 10.1371/journal.pone.0213579. eCollection 2019.

5.

Effects of lithium on the secretory production of recombinant antibody from insect cells.

Ohmuro-Matsuyama Y, Katsuda T, Yamaji H.

In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):1-6. doi: 10.1007/s11626-018-0303-1. Epub 2018 Oct 31.

PMID:
30382493
6.

Evaluation of protein-ligand interactions using the luminescent interaction assay FlimPIA with streptavidin-biotin linkage.

Ohmuro-Matsuyama Y, Yamashita T, Gomi K, Yamaji H, Ueda H.

Anal Biochem. 2018 Dec 15;563:61-66. doi: 10.1016/j.ab.2018.10.010. Epub 2018 Oct 11.

PMID:
30316750
7.

Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.

Heart Vessels. 2019 Feb;34(2):331-342. doi: 10.1007/s00380-018-1238-x. Epub 2018 Aug 7.

PMID:
30088055
8.

Modification of N-Terminal Amino Acids of Fungal Benzoate Hydroxylase (CYP53A15) for the Production of p-Hydroxybenzoate and Optimization of Bioproduction Conditions in Escherichia coli.

Tamaki S, Yagi M, Nishihata Y, Yamaji H, Shigeri Y, Uno T, Imaishi H.

J Microbiol Biotechnol. 2018 Mar 28;28(3):439-447. doi: 10.4014/jmb.1711.11030.

9.

Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.

J Cardiovasc Electrophysiol. 2018 Jun;29(6):835-843. doi: 10.1111/jce.13483. Epub 2018 Mar 30.

PMID:
29533476
10.

Botanical origin and chemical constituents of commercial Saposhnikoviae radix and its related crude drugs available in Shaanxi and the surrounding regions.

Maruyama T, Ezaki M, Shiba M, Yamaji H, Yoshitomi T, Kawano N, Zhu S, Cheng X, Yokokura T, Yamamoto Y, Fuchino H, Sun H, Komatsu K, Kawahara N.

J Nat Med. 2018 Jan;72(1):267-273. doi: 10.1007/s11418-017-1149-7. Epub 2017 Nov 17.

PMID:
29149424
11.

Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence.

Higashiya S, Yamaji H, Murakami T, Hina K, Kawamura H, Murakami M, Kamikawa S, Komatsubara I, Kusachi S.

Open Heart. 2017 Mar 27;4(1):e000593. doi: 10.1136/openhrt-2017-000593. eCollection 2017.

12.

Improved sensitivity of firefly luminescent intermediate-based protein interaction assay using Ser 440 mutant with lower adenylation activity.

Ohmuro-Matsuyama Y, Yamashita T, Lin H, Yamaji H, Ueda H.

Luminescence. 2018 Feb;33(1):125-130. doi: 10.1002/bio.3381. Epub 2017 Jul 28.

PMID:
28752574
13.

Modifications of a signal sequence for antibody secretion from insect cells.

Ohmuro-Matsuyama Y, Yamaji H.

Cytotechnology. 2018 Jun;70(3):891-898. doi: 10.1007/s10616-017-0109-0. Epub 2017 Jun 5.

14.

Efficient production of antibody Fab fragment by transient gene expression in insect cells.

Mori K, Hamada H, Ogawa T, Ohmuro-Matsuyama Y, Katsuda T, Yamaji H.

J Biosci Bioeng. 2017 Aug;124(2):221-226. doi: 10.1016/j.jbiosc.2017.03.007. Epub 2017 Apr 11.

PMID:
28410897
15.

Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Komatsubara I, Kusachi S.

J Cardiovasc Pharmacol. 2017 Feb;69(2):118-126. doi: 10.1097/FJC.0000000000000448.

16.

Response to Comment on "A bacterium that degrades and assimilates poly(ethylene terephthalate)".

Yoshida S, Hiraga K, Takehana T, Taniguchi I, Yamaji H, Maeda Y, Toyohara K, Miyamoto K, Kimura Y, Oda K.

Science. 2016 Aug 19;353(6301):759. doi: 10.1126/science.aaf8625.

17.

Evaluation of Simultaneous Dual-radioisotope SPECT Imaging Using (18)F-fluorodeoxyglucose and (99m)Tc-tetrofosmin.

Takahashi Y, Mochiki M, Koyama K, Ino T, Yamaji H, Kawakami A.

Asia Ocean J Nucl Med Biol. 2016 Summer;4(2):66-71. doi: 10.7508/aojnmb.2016.02.002.

18.

Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Komtasubara I, Kusachi S.

Clin Drug Investig. 2016 Oct;36(10):837-48. doi: 10.1007/s40261-016-0435-6.

19.

Production of Japanese Encephalitis Virus-Like Particles Using Insect Cell Expression Systems.

Yamaji H, Konishi E.

Methods Mol Biol. 2016;1404:365-75. doi: 10.1007/978-1-4939-3389-1_25.

PMID:
27076311
20.

A bacterium that degrades and assimilates poly(ethylene terephthalate).

Yoshida S, Hiraga K, Takehana T, Taniguchi I, Yamaji H, Maeda Y, Toyohara K, Miyamoto K, Kimura Y, Oda K.

Science. 2016 Mar 11;351(6278):1196-9. doi: 10.1126/science.aad6359.

21.

Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.

Shirakata Y, Fukuda K, Fujita T, Nakano Y, Nomoto H, Yamaji H, Shiraga F, Tsujikawa A.

Clin Ophthalmol. 2016 Feb 5;10:277-83. doi: 10.2147/OPTH.S85751. eCollection 2016.

22.

Electrostatic engineering of the interface between heavy and light chains promotes antibody Fab fragment production.

Ohmuro-Matsuyama Y, Mori K, Hamada H, Ueda H, Yamaji H.

Cytotechnology. 2017 Jun;69(3):469-475. doi: 10.1007/s10616-016-9955-4. Epub 2016 Feb 8.

23.

Ultra sensitive firefly luciferase-based protein-protein interaction assay (FlimPIA) attained by hinge region engineering and optimized reaction conditions.

Kurihara M, Ohmuro-Matsuyama Y, Ayabe K, Yamashita T, Yamaji H, Ueda H.

Biotechnol J. 2016 Jan;11(1):91-9. doi: 10.1002/biot.201500189. Epub 2015 Nov 25.

PMID:
26384153
24.

Baculovirus display of functional antibody Fab fragments.

Takada S, Ogawa T, Matsui K, Suzuki T, Katsuda T, Yamaji H.

Cytotechnology. 2015 Aug;67(4):741-7. doi: 10.1007/s10616-015-9876-7. Epub 2015 Apr 24.

25.

Effects of temperature on the astaxanthin productivity and light harvesting characteristics of the green alga Haematococcus pluvialis.

Giannelli L, Yamada H, Katsuda T, Yamaji H.

J Biosci Bioeng. 2015 Mar;119(3):345-50. doi: 10.1016/j.jbiosc.2014.09.002. Epub 2014 Nov 7.

PMID:
25441445
26.

A method to decrease the frequency of unintentional slippage after vitrectomy for rhegmatogenous retinal detachment.

Shiragami C, Fukuda K, Yamaji H, Morita M, Shiraga F.

Retina. 2015 Apr;35(4):758-63. doi: 10.1097/IAE.0000000000000383.

PMID:
25341884
27.

Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.

Sekine Y, Yanagibori R, Suzuki K, Sugiyama S, Yamaji H, Ishibashi M, Fujisawa T.

Int J Chron Obstruct Pulmon Dis. 2014 Jun 23;9:647-56. doi: 10.2147/COPD.S62053. eCollection 2014.

28.

Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.

Yamaji H.

Appl Microbiol Biotechnol. 2014 Mar;98(5):1963-70. doi: 10.1007/s00253-013-5474-9. Epub 2014 Jan 10. Review.

PMID:
24407451
29.

Production of Japanese encephalitis virus-like particles in insect cells.

Yamaji H, Konishi E.

Bioengineered. 2013 Nov-Dec;4(6):438-42. doi: 10.4161/bioe.24514. Epub 2013 May 2.

30.

Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.

Clin Drug Investig. 2013 Jun;33(6):409-18. doi: 10.1007/s40261-013-0081-1.

PMID:
23572324
31.

Combined 25-gauge vitrectomy and cataract surgery with toric intraocular lens with idiopathic epiretinal membrane.

Nakano Y, Nomoto H, Fukuda K, Yamaji H, Fujita T, Inoue Y, Shiraga F.

J Cataract Refract Surg. 2013 May;39(5):686-93. doi: 10.1016/j.jcrs.2012.11.029. Epub 2013 Mar 13.

PMID:
23489916
32.

Adaptive-servo ventilation combined with deep sedation is an effective strategy during pulmonary vein isolation.

Murakami T, Yamaji H, Numa K, Kawamura H, Murakami M, Higashiya S, Kamikawa S, Hina K, Hirohata S, Kusachi S.

Europace. 2013 Jul;15(7):951-6. doi: 10.1093/europace/eut007. Epub 2013 Feb 17.

PMID:
23419657
33.

Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells.

Yamaji H, Nakamura M, Kuwahara M, Takahashi Y, Katsuda T, Konishi E.

Appl Microbiol Biotechnol. 2013 Feb;97(3):1071-9. doi: 10.1007/s00253-012-4371-y. Epub 2012 Sep 5.

PMID:
22948954
34.

Production of antibody fragments using the baculovirus-insect cell system.

Furuta T, Ogawa T, Yamaji H.

Methods Mol Biol. 2012;907:371-87. doi: 10.1007/978-1-61779-974-7_22.

PMID:
22907364
35.

Production of antibody fragments in Escherichia coli.

Katsuda T, Sonoda H, Kumada Y, Yamaji H.

Methods Mol Biol. 2012;907:305-24. doi: 10.1007/978-1-61779-974-7_18.

PMID:
22907360
36.

Production of Japanese encephalitis virus-like particles using the baculovirus-insect cell system.

Yamaji H, Segawa M, Nakamura M, Katsuda T, Kuwahara M, Konishi E.

J Biosci Bioeng. 2012 Dec;114(6):657-62. doi: 10.1016/j.jbiosc.2012.06.012. Epub 2012 Jul 28.

PMID:
22841798
37.

Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer.

Koh E, Iizasa T, Yamaji H, Sekine Y, Hiroshima K, Yoshino I, Fujisawa T.

Int J Surg Pathol. 2012 Jun;20(3):233-9. doi: 10.1177/1066896911436274. Epub 2012 Feb 13.

PMID:
22334615
38.

Correlation of increased fundus autofluorescence signals at closed macula with visual prognosis after successful macular hole surgery.

Shiragami C, Shiraga F, Nitta E, Fukuda K, Yamaji H.

Retina. 2012 Feb;32(2):281-8. doi: 10.1097/IAE.0b013e31821e208f.

PMID:
21909053
39.

Sufficient pulmonary vein image quality of non-enhanced multi-detector row computed tomography for pulmonary vein isolation by catheter ablation.

Yamaji H, Hina K, Kawamura H, Murakami T, Murakami M, Hirohata S, Ohmaru N, Kusachi S.

Europace. 2012 Jan;14(1):52-9. doi: 10.1093/europace/eur284. Epub 2011 Sep 8.

PMID:
21908449
40.

Morphologic and functional advantages of macular hole surgery with brilliant blue G-assisted internal limiting membrane peeling.

Fukuda K, Shiraga F, Yamaji H, Nomoto H, Shiragami C, Enaida H, Ishibashi T.

Retina. 2011 Sep;31(8):1720-5. doi: 10.1097/IAE.0b013e31822a33d0. No abstract available.

PMID:
21878802
41.

[Medium-term effects of intravitreal bevacizumab for macular edema associated with central retinal vein occlusion].

Ono A, Fukuda K, Yamashita A, Shiragami C, Yamaji H, Shiraga F.

Nippon Ganka Gakkai Zasshi. 2011 Apr;115(4):382-5. Japanese. Erratum in: Nippon Ganka Gakkai Zasshi. 2011 Jun;115(6):547.

PMID:
21598607
42.

Effects of cytoplasmic and periplasmic chaperones on secretory production of single-chain Fv antibody in Escherichia coli.

Sonoda H, Kumada Y, Katsuda T, Yamaji H.

J Biosci Bioeng. 2011 Apr;111(4):465-70. doi: 10.1016/j.jbiosc.2010.12.015. Epub 2011 Feb 16.

PMID:
21324738
43.

Epigenetic gene silencing is a novel mechanism involved in delayed manifestation of radiation-induced genomic instability in mammalian cells.

Suzuki K, Yamaji H, Kobashigawa S, Kawauchi R, Shima K, Kodama S, Watanabe M.

Radiat Res. 2011 Apr;175(4):416-23. doi: 10.1667/RR2391.1. Epub 2011 Feb 9.

PMID:
21306201
44.

Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy.

Yamaji H, Shiraga F, Shiragami C, Nomoto H, Fujita T, Fukuda K.

Arch Ophthalmol. 2011 Jan;129(1):106-7. doi: 10.1001/archophthalmol.2010.333. No abstract available.

PMID:
21220639
45.

Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.

Yoshikado T, Takada T, Yamamoto T, Yamaji H, Ito K, Santa T, Yokota H, Yatomi Y, Yoshida H, Goto J, Tsuji S, Suzuki H.

Mol Pharmacol. 2011 Feb;79(2):241-50. doi: 10.1124/mol.110.067256. Epub 2010 Nov 5.

PMID:
21056966
46.

Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery.

Oshima Y, Kadonosono K, Yamaji H, Inoue M, Yoshida M, Kimura H, Ohji M, Shiraga F, Hamasaki T; Japan Microincision Vitrectomy Surgery Study Group.

Am J Ophthalmol. 2010 Nov;150(5):716-725.e1. doi: 10.1016/j.ajo.2010.06.002. Epub 2010 Aug 16.

PMID:
20719299
47.

Efficient production of an antibody Fab fragment using the baculovirus-insect cell system.

Furuta T, Ogawa T, Katsuda T, Fujii I, Yamaji H.

J Biosci Bioeng. 2010 Nov;110(5):577-81. doi: 10.1016/j.jbiosc.2010.06.001. Epub 2010 Jun 29.

PMID:
20591732
48.

Vascular endothelial growth factor concentrations in aqueous humor before and after subconjunctival injection of bevacizumab for neovascular glaucoma.

Mizote M, Baba T, Hirooka K, Yamaji H, Shiraga F.

Jpn J Ophthalmol. 2010 May;54(3):242-4. doi: 10.1007/s10384-009-0788-y. Epub 2010 Jun 25. No abstract available.

PMID:
20577861
49.

Genetic and chemical comparison of Boi (Sinomeni Caulis et Rhizoma) and Seifuto (Caulis Sinomenii).

Sano T, Matsumura I, Nakamura R, Yamaji H, Hashimoto K, Takeda O, Kiuchi F, Takeda T.

J Nat Med. 2010 Jul;64(3):257-65. doi: 10.1007/s11418-010-0397-6. Epub 2010 Mar 9.

PMID:
20217263
50.

Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.

Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T.

J Am Coll Cardiol. 2010 Mar 9;55(10):976-82. doi: 10.1016/j.jacc.2009.09.062.

Supplemental Content

Loading ...
Support Center